Nuvation Bio Inc. Debt Securities, Available-for-sale, Realized Loss
Nuvation Bio Inc. (NUVB) reported Debt Securities, Available-for-sale, Realized Loss of $11.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2026-08-06
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for the quarter ending 2026-06-30 was $11.00K, a 1000.00% increase year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for the quarter ending 2026-03-31 was $0.00.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for fiscal 2025 was $1.00K, a 98.11% decline from fiscal 2024.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for fiscal 2024 was $53.00K, a 74.64% decline from fiscal 2023.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for fiscal 2023 was $209.00K, a 80.38% decline from fiscal 2022.
- Nuvation Bio Inc. debt securities, available-for-sale, realized loss for fiscal 2022 was $1.06M, a 53150.00% increase from fiscal 2021.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month | Debt Securities, Available-for-sale, Realized Loss 12 month | Debt Securities, Available-for-sale, Realized Loss 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $11.00K 10-Q · filed 2026-08-06 | $11.00K 10-Q · filed 2026-08-06 | $11.00K derived: sum of 3 quarters · filed 2026-08-06 | $11.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-04 | $0.00 derived: sum of 2 quarters · filed 2026-05-04 | $0.00 derived: sum of 3 quarters · filed 2026-05-04 | $1.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | $1.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-03 | $1.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.00K 10-Q · filed 2025-11-03 | $26.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-06 | $1.00K 10-Q · filed 2026-08-06 | $26.00K derived: sum of 3 quarters · filed 2026-08-06 | $47.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-04 | $25.00K derived: sum of 2 quarters · filed 2026-05-04 | $46.00K derived: sum of 3 quarters · filed 2026-05-04 | $54.00K derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $46.00K derived: sum of 2 quarters · filed 2026-03-02 | $54.00K derived: sum of 3 quarters · filed 2026-03-02 | $53.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $21.00K 10-Q · filed 2025-11-03 | $29.00K derived: sum of 2 quarters · filed 2025-11-03 | $28.00K 10-Q · filed 2025-11-03 | $28.00K derived: sum of 4 quarters · filed 2025-11-03 | |
| 2024-06-30 | $8.00K 10-Q · filed 2025-08-07 | $7.00K 10-Q · filed 2025-08-07 | $7.00K derived: sum of 3 quarters · filed 2025-08-07 | $10.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-07 | -$1.00K derived: sum of 2 quarters · filed 2025-05-07 | $2.00K derived: sum of 3 quarters · filed 2025-05-07 | $113.00K derived: sum of 4 quarters · filed 2025-05-07 | |
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $2.00K derived: sum of 2 quarters · filed 2025-03-06 | $113.00K derived: sum of 3 quarters · filed 2025-03-06 | $209.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | $3.00K 10-Q · filed 2024-11-06 | $114.00K derived: sum of 2 quarters · filed 2024-11-06 | $210.00K 10-Q · filed 2024-11-06 | $338.00K derived: sum of 4 quarters · filed 2024-11-06 | |
| 2023-06-30 | $111.00K 10-Q · filed 2024-08-05 | $207.00K 10-Q · filed 2024-08-05 | $335.00K derived: sum of 3 quarters · filed 2024-08-05 | $527.00K derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | $96.00K 10-Q · filed 2024-05-14 | $224.00K derived: sum of 2 quarters · filed 2024-05-14 | $416.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.11M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $320.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.01M derived: sum of 3 quarters · filed 2024-02-29 | $1.06M 10-K · filed 2024-02-29 | -$1.06M 10-K · filed 2023-03-15 |
| 2022-09-30 | $192.00K 10-Q · filed 2023-11-02 | $887.00K derived: sum of 2 quarters · filed 2023-11-02 | $937.00K 10-Q · filed 2023-11-02 | $939.00K derived: sum of 4 quarters · filed 2023-11-02 | |
| 2022-06-30 | $695.00K 10-Q · filed 2023-08-03 | $745.00K 10-Q · filed 2023-08-03 | $747.00K derived: sum of 3 quarters · filed 2023-08-03 | $747.00K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-04 | $52.00K derived: sum of 2 quarters · filed 2023-05-04 | $52.00K derived: sum of 3 quarters · filed 2023-05-04 | $52.00K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $2.00K derived: sum of 2 quarters · filed 2023-03-15 | $2.00K derived: sum of 3 quarters · filed 2023-03-15 | $2.00K 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $0.00 derived: sum of 2 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | $95.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |